| Name | Title | Contact Details |
|---|---|---|
Dustin Holloway |
AI Governance Professional | AI Scientist and experienced Executive | Vice President and Global Head of Responsible Innovation | PhD, MPH, AIGP | Profile |
Jonathan Amar |
Assistant General Counsel | Profile |
Ellen McCabe |
Assistant General Counsel | Profile |
Jessica Weber |
Senior Corporate Counsel, Specialty Care | Profile |
Stephanie Donahue |
Head of Global Patent Litigation | Profile |
We are a specialty pharmaceutical company developing transformative therapies to advance the treatment of gastrointestinal (GI) disorders. We focus on developing treatments for GI disorders for which meaningful therapeutic innovation is required to satisfy unmet patient need and disease burden. Our management team and board of directors are comprised of professionals with extensive backgrounds in drug research and development, commercialization, finance and business development for leading global pharmaceutical companies and growth-stage biopharmaceutical companies. Our scientific advisory board consists of well-known gastroenterologists and clinical thought leaders. Today, our pipeline consists of two unique clinical stage therapies with the potential to bring benefit to millions of patients with chronic and debilitating GI disorders that are not adequately controlled.
FDC Vitamins is a Hialeah, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
All-american Allergy Alternatives is a Appleton, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Paragon 28 was established for unmet needs of the foot and ankle community. Dedicated to creating solutions to improve the treatment of foot and ankle conditions.
United Pharma is a Fullerton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.